CA2310207A1 - Topical zinc compositions and methods of use - Google Patents

Topical zinc compositions and methods of use Download PDF

Info

Publication number
CA2310207A1
CA2310207A1 CA002310207A CA2310207A CA2310207A1 CA 2310207 A1 CA2310207 A1 CA 2310207A1 CA 002310207 A CA002310207 A CA 002310207A CA 2310207 A CA2310207 A CA 2310207A CA 2310207 A1 CA2310207 A1 CA 2310207A1
Authority
CA
Canada
Prior art keywords
methods
compositions
zinc compositions
zinc
topical zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002310207A
Other languages
French (fr)
Other versions
CA2310207C (en
Inventor
Helen R. Godfrey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2310207A1 publication Critical patent/CA2310207A1/en
Application granted granted Critical
Publication of CA2310207C publication Critical patent/CA2310207C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/06—Chelate

Abstract

Compositions including zinc compounds and select amino acids in a carrier base, and methods of skin treatment with such compositions, are described. The compositions are useful for healing skin and minimizing the irritation incurred from contact with the zinc compound without loss of zinc availability during absorption into the integument.
CA002310207A 1999-06-14 2000-05-29 Topical zinc compositions and methods of use Expired - Fee Related CA2310207C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/332,508 1999-06-14
US09/332,508 US6558710B1 (en) 1999-06-14 1999-06-14 Topical zinc compositions and methods of use

Publications (2)

Publication Number Publication Date
CA2310207A1 true CA2310207A1 (en) 2000-12-14
CA2310207C CA2310207C (en) 2004-08-03

Family

ID=23298532

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002310207A Expired - Fee Related CA2310207C (en) 1999-06-14 2000-05-29 Topical zinc compositions and methods of use

Country Status (11)

Country Link
US (2) US6558710B1 (en)
EP (1) EP1064946B1 (en)
JP (1) JP3706792B2 (en)
AT (1) ATE349217T1 (en)
AU (1) AU776318B2 (en)
BR (1) BR0002638A (en)
CA (1) CA2310207C (en)
DE (1) DE60032543T2 (en)
IL (1) IL136453A (en)
NZ (1) NZ504829A (en)
ZA (1) ZA200002767B (en)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6864231B2 (en) 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations
TNSN02063A1 (en) * 2001-07-07 2005-12-23 Egyptian Natural Oil Co Natoil The medical effect of jojoba oil
DE10160933B4 (en) * 2001-12-12 2018-06-21 Evonik Degussa Gmbh Deodorizing compositions containing the zinc salt of ricinoleic acid and at least one amino-functional amino acid
US6932976B2 (en) * 2002-08-08 2005-08-23 Kimberly-Clark Worldwide, Inc. Enzyme blocking skin protectant cream
KR20120008081A (en) * 2002-10-25 2012-01-25 레반스 테라퓨틱스, 아이엔씨. Modulation of zinc levels to improve tissue properties
US20080274209A1 (en) * 2002-11-04 2008-11-06 Integritas Pharma, Inc. Methods of treating inflammation
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
US20040101507A1 (en) * 2002-11-27 2004-05-27 Janco Predovan Skin cream
BRPI0415766A (en) * 2003-10-22 2006-12-26 Council Of Scientifc & Ind Res use of selected zinc-amino acid complexes as anti-malarial
WO2006135445A2 (en) * 2004-11-03 2006-12-21 Albion Laboratories, Inc. Antimicrobial chelates
EP1827464A4 (en) * 2004-12-23 2010-06-23 Swiss American Products Inc Zinc-based compositions and methods of use
US20060147507A1 (en) * 2005-01-04 2006-07-06 Marie Cammarata Hot flash treatment system
US20070031509A1 (en) * 2005-08-04 2007-02-08 Sundae Laxman S Breakthrough to cure psoriasis, psoriatic arthritis and treatment of other unrelated skin disorders, and external rectal and genital itching
US20070082035A1 (en) * 2005-10-06 2007-04-12 New York Blood Center, Inc. Anti-infective hygiene products based on cellulose acetate phthalate
CN101340889A (en) * 2005-12-21 2009-01-07 高露洁-棕榄公司 Improved oral compositions comprising zinc citrate and/or tocopherol agents
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
PL1993569T3 (en) 2006-02-03 2014-11-28 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
GB0617191D0 (en) * 2006-08-31 2006-10-11 York Pharma Plc Improvements in pharmaceutical compositions
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
EP2418945B1 (en) 2009-04-15 2018-12-05 BMG PHARMA S.p.A. Mineral salt-sulfonic acid compositions and methods of use
AU2009354789B2 (en) 2009-10-29 2013-06-13 Colgate-Palmolive Company Dentifrice comprising stannous fluoride plus zinc citrate and low levels of water
JP5694506B2 (en) 2010-03-31 2015-04-01 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ Oral care composition
WO2012058675A2 (en) 2010-10-29 2012-05-03 Mary Kay Inc. Zinc oxide complexes
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
DE102011006315A1 (en) * 2011-03-29 2012-10-04 Henkel Ag & Co. Kgaa Detergents or cleaning agents with modified fragrances
WO2013091894A2 (en) 2011-12-21 2013-06-27 Flavin Dana Topical compositions
DE202012103733U1 (en) 2012-09-28 2012-11-15 Reiner Rittinghausen Composition for nutritive supplementation or treatment for herpes
AU2012397266B2 (en) 2012-12-19 2015-09-24 Colgate-Palmolive Company Oral care products comprising a tetrabasic zinc - amino acid - halide complex
RU2636612C2 (en) 2012-12-19 2017-11-24 Колгейт-Палмолив Компани Compositions for oral care, containing zinc complex with amino acid and halogenide
ES2617492T3 (en) 2012-12-19 2017-06-19 Colgate-Palmolive Company Antiperspirant products with protein and antiperspirant salts
RU2648513C2 (en) 2012-12-19 2018-03-26 Колгейт-Палмолив Компани Zinc amino acid halide mouthwash
WO2014204439A1 (en) * 2013-06-18 2014-12-24 Colgate-Palmolive Company Zinc amino acid halide complex with cysteine
WO2014098821A1 (en) * 2012-12-19 2014-06-26 Colgate-Palmolive Company Method for indicating time for washing or indicating delivery of antibacterial agent
US20190104741A1 (en) * 2012-12-19 2019-04-11 Colgate-Palmolive Company Personal Cleansing Compositions Containing Zinc Amino Acid / Trimethylglycine Halide
US10188112B2 (en) * 2012-12-19 2019-01-29 Colgate-Palmolive Company Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
US9504858B2 (en) 2012-12-19 2016-11-29 Colgate-Palmolive Company Zinc amino acid halide complex with cysteine
US9943473B2 (en) * 2012-12-19 2018-04-17 Colgate-Palmolive Company Zinc lysine halide complex
US9675823B2 (en) 2012-12-19 2017-06-13 Colgate-Palmolive Company Two component compositions containing zinc amino acid halide complexes and cysteine
US9498421B2 (en) 2012-12-19 2016-11-22 Colgate-Palmolive Company Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine
US10494589B2 (en) 2012-12-19 2019-12-03 Colgate-Palmolive Company Method for indicating time for washing or indicating delivery of antibacterial agent
WO2014098828A1 (en) 2012-12-19 2014-06-26 Colgate-Palmolive Company Teeth whitening methods, visually perceptible signals and compositions therefor|comprising zinc amino acid halides
US9750670B2 (en) 2012-12-19 2017-09-05 Colgate-Palmolive Company Zinc amino acid complex with cysteine
RU2636226C2 (en) 2012-12-19 2017-11-21 Колгейт-Палмолив Компани Gel for oral care, containing zinc complex and amino acids
CN104854114B (en) 2012-12-19 2018-05-08 高露洁-棕榄公司 zinc-lysine complex
CA2892179C (en) 2012-12-19 2020-03-31 Colgate-Palmolive Company Composition with zinc amino acid/trimethylglycine halide precursors
JP5976955B2 (en) 2012-12-19 2016-08-24 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ Oral care products containing zinc oxide and trimethylglycine
WO2014098827A1 (en) 2012-12-19 2014-06-26 Colgate-Palmolive Company Oral care products comprising tetrabasic zinc chloride and trimethylglycine
CA2892190C (en) * 2012-12-19 2020-10-27 Colgate-Palmolive Company Zinc amino acid complex with cysteine
CN105077280A (en) * 2015-09-01 2015-11-25 张伟 Liquid preparation for supplementing zinc and preparation method thereof
CN108366922B (en) * 2015-12-22 2021-12-28 高露洁-棕榄公司 Oral care compositions comprising zinc amino acid halide
ES2638195B1 (en) 2016-04-18 2018-08-02 Bioiberica, S.A. SKIN COMPOSITIONS
CA3038870A1 (en) 2016-10-13 2018-04-19 Trilogic Pharma Llc Lidocaine formulations for use in chronic open wounds
CN110099663B (en) * 2016-12-14 2022-10-28 高露洁-棕榄公司 Aluminum-free antiperspirant/deodorant compositions
EP3838251A1 (en) * 2016-12-14 2021-06-23 Colgate-Palmolive Company Aluminum-free antiperspirant/deodorant compositions
WO2018111705A1 (en) 2016-12-14 2018-06-21 Colgate-Palmolive Company Aluminum-free antiperspirant/deodorant compositions
US10960129B2 (en) 2017-08-25 2021-03-30 AZ Solutions LLC System and method for patient skin treatment and irrigation
US11918549B2 (en) 2017-08-25 2024-03-05 AZ Solutions LLC System and method for wound treatment and irrigation
US11147761B2 (en) * 2018-01-12 2021-10-19 Nicole Akmenkalns Topical supplement composition and method of use
US20220047590A1 (en) * 2019-04-11 2022-02-17 Cmpd Licensing, Llc Wound treatments and compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77562A1 (en) 1977-06-17 1979-03-26 Ciba Geigy Ag METHOD FOR PRODUCING NEW PHARMACEUTICAL PREPARATIONS
US4425325A (en) 1979-06-20 1984-01-10 Lever Brothers Company Oral compositions
US4339432A (en) 1979-06-20 1982-07-13 Lever Brothers Company Oral mouthwash containing zinc and glycine
GB2080682B (en) 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
US4372296A (en) 1980-11-26 1983-02-08 Fahim Mostafa S Treatment of acne and skin disorders and compositions therefor
US4407818A (en) 1980-12-17 1983-10-04 Bio-Systems Research, Inc. Anti viral, anti bacterial and/or anti fungal composition containing metal oxyalkylate
US5409905A (en) 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US5095035A (en) 1981-07-31 1992-03-10 Eby Iii George A Flavor stable zinc acetate compositions for oral absorption
JPS57158724A (en) * 1981-03-26 1982-09-30 Shiseido Co Ltd Antimicrobial composition
US4565693A (en) * 1981-11-09 1986-01-21 Colgate-Palmolive Company Deodorant composition
US4847283A (en) 1983-01-10 1989-07-11 Harendza Harinxma Alfred J Ointment and method for treating skin lesions due to herpes virus
US4758439A (en) 1984-06-11 1988-07-19 Godfrey Science & Design, Inc. Flavor of zinc supplements for oral use
EP0183840B1 (en) 1984-06-11 1994-03-02 GODFREY SCIENCE & DESIGN, INC. Improvement in the flavor of zinc supplements for oral use
US4711780A (en) 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4830716B1 (en) * 1986-07-03 1999-12-07 Albion Int Preparation of pharmaceutical grade amino acid chelates
NZ223558A (en) * 1987-02-18 1990-04-26 Milor Scient Ltd Acne treatment composition
US4937234A (en) 1988-08-10 1990-06-26 Fahim Mostafa S Minerals in bioavailable form
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
US5599551A (en) 1989-06-06 1997-02-04 Kelly; Patrick D. Genital lubricants containing zinc as an anti-viral agent
US5785054A (en) 1989-06-06 1998-07-28 Kelly; Patrick D. Genital lubricant with zinc salt, labelled as anti-viral agent
US5545673A (en) 1989-06-06 1996-08-13 Kelly; Patrick D. Method for reducing risk of infection by sexually transmitted viruses
US5624675A (en) 1989-06-06 1997-04-29 Kelly; Patrick D. Genital lubricants containing zinc salts to reduce risk of HIV infection
US5482053A (en) 1989-06-06 1996-01-09 Kelly; Patrick D. Condom lubricants containing zinc as an anti-viral agent
US5514667A (en) 1990-11-05 1996-05-07 Arthropharm Pty. Limited Method for topical treatment of herpes infections
US5260066A (en) 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
TW233264B (en) 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
US5696169A (en) * 1992-03-13 1997-12-09 Otsuka Pharmaceutical Co., Ltd. Antibacterial and antifungal activity method, therapeutic method of infectious diseases and preserving method of cosmetics
US5463098A (en) * 1992-11-16 1995-10-31 Giovanniello; Rocco Clear antiperspirant gel stick and method for making same
CA2184828C (en) 1994-03-28 2008-08-12 Shanta M. Modak Composition for inactivating irritants in fluids
FR2742990B1 (en) * 1995-12-28 1998-03-27 Fabre Pierre Dermo Cosmetique ANTIBACTERIAL COMPOSITION BASED ON ACYLGLYCIN AND ZINC SALT
US5759559A (en) 1997-05-05 1998-06-02 Fitzjarrell; Edwin A. Method and composition for treating acne

Also Published As

Publication number Publication date
ATE349217T1 (en) 2007-01-15
NZ504829A (en) 2001-04-27
DE60032543T2 (en) 2007-10-04
IL136453A (en) 2005-09-25
DE60032543D1 (en) 2007-02-08
EP1064946A3 (en) 2003-05-02
EP1064946A2 (en) 2001-01-03
US6558710B1 (en) 2003-05-06
CA2310207C (en) 2004-08-03
EP1064946B1 (en) 2006-12-27
BR0002638A (en) 2001-01-02
US20030077332A1 (en) 2003-04-24
JP3706792B2 (en) 2005-10-19
JP2001010960A (en) 2001-01-16
ZA200002767B (en) 2001-02-28
IL136453A0 (en) 2001-06-14
AU776318B2 (en) 2004-09-02
AU3943100A (en) 2000-12-21

Similar Documents

Publication Publication Date Title
CA2310207A1 (en) Topical zinc compositions and methods of use
CA2304969A1 (en) Mouth hygienic composition for the treatment of halitosis
CA2195213A1 (en) Use of droloxifene for the treatment of cardiovascular diseases
HUP0000575A3 (en) Novel formulation comprising budesonid as active indegredient
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
CA2262870A1 (en) Liposome-based topical vitamin d formulation
CA2069153A1 (en) Pharmaceutical composition
CA2147341A1 (en) Skin treatment composition comprising l-lactic acid and n-acetyl-l-cysteine
WO1999043355A3 (en) Formulations containing oxaliplatin
CA2387873A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
CA2186269A1 (en) Wound healing
GB9203299D0 (en) Cosmetic and/or pharmaceutical compositions and methods for their use
CA2267309A1 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ES2137125A1 (en) Use of the zinc salt of glycyrrhetic acid in preparations against acne, and the compositions which contain said salt.
CA2247198A1 (en) Topical pharmaceutical composition containing heparin
AU2028995A (en) L-lysyl-glycyl-L-histidine and therapeutic agent for wound healing containing the same
AU8851298A (en) L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
ZA972180B (en) Topical formulations for the treatment of psoriasis of the nail.
CA2018791A1 (en) Hair treatment composition
CA2279962A1 (en) An anhydrous antiperspirant composition comprising a pentane propellant
CA2283450A1 (en) Methods for treatment of scar tissue
ZA200006081B (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-A/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150529